Japan Transfection Reagents & Equipment Market Size & Outlook
Japan transfection reagents & equipment market, 2016-2028 (US$M)
Related Markets
Japan transfection reagents & equipment market highlights
- The Japan transfection reagents & equipment market generated a revenue of USD 62.5 million in 2020 and is expected to reach USD 132.7 million by 2028.
- The Japan market is expected to grow at a CAGR of 9.9% from 2021 to 2028.
- In terms of segment, reagents was the largest revenue generating product in 2020.
- Equipment is the most lucrative product segment registering the fastest growth during the forecast period.
Transfection reagents & equipment market data book summary
| Market revenue in 2020 | USD 62.5 million |
| Market revenue in 2028 | USD 132.7 million |
| Growth rate | 9.9% (CAGR from 2020 to 2028) |
| Largest segment | Reagents |
| Fastest growing segment | Equipment |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents, Equipment |
| Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Qiagen NV, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Merck KGaA, Origin Enterprises PLC, MaxCyte Inc, PromoCell GmbH, Promega, Polyplus-transfection, Horizon Discovery |
Other key industry trends
- In terms of revenue, Japan accounted for 6.4% of the global transfection reagents & equipment market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Asia Pacific, Japan transfection reagents & equipment market is projected to lead the regional market in terms of revenue in 2028.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 126.9 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Transfection Reagents & Equipment Market Scope
Transfection Reagents & Equipment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan transfection reagents & equipment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transfection reagents & equipment market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 54.88% in 2020. Horizon Databook has segmented the Japan transfection reagents & equipment market based on reagents, equipment covering the revenue growth of each sub-segment from 2016 to 2028.
A strong concentration of local manufacturers operating in transfection reagents and equipment market is expected to drive the growth of Japanese market. For instance, Takara Bio Inc. is a well-established market player headquartered in Japan.
Another local manufacturer namely, Nepa Gene Co., Ltd., offers transfection systems such as NEPA21 Super Electroporator, NEPA21 Cuvette Electroporation, and NEPA21 Cell-Culture-Plate Electroporation.
Reasons to subscribe to Japan transfection reagents & equipment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan transfection reagents & equipment market databook
-
Our clientele includes a mix of transfection reagents & equipment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan transfection reagents & equipment market , including forecasts for subscribers. This country databook contains high-level insights into Japan transfection reagents & equipment market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Japan transfection reagents & equipment market size, by product, 2016-2028 (US$M)
Japan Transfection Reagents & Equipment Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
